Morroniside alleviates CoCrMo particle-induced osteogenic impairment by activating Wnt/β-catenin signalling
Cellular Signalling · 2026-10 · 146 · 112687
DOI: 10.1016/j.cellsig.2026.112687 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2026-10. Verfasst von Jing Han und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China; State Key Laboratory of Technologies for Chinese Medicine Pharmace…. Hauptthemen laut MEDLINE: Osteogenesis, Wnt Signaling Pathway, Glycosides, Osteolysis. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Nanjing University, Chongqing Natural Science Foundation, Nanjing University of Chinese Medicine.
Abstract (Originalsprache)
Periprosthetic osteolysis (PPO) is the main cause of aseptic loosening after total joint arthroplasty, often resulting from wear particle-induced osteogenic impairment. Morroniside (Mor), a major bioactive iridoid glycoside from C. officinalis, has been shown to have protective effects in osteoporosis. However, its efficacy against wear particle-induced osteolysis remains elusive. Herein, we evaluated the anti-PPO efficacy of Mor using a CoCrMo particle (CoP)-induced murine calvarial osteolysis model, and investigated the protective effects and signalling pathways associated with osteogenesis in CoP-stimulated mice and MC3T3-E1 cells. The results demonstrated that Mor effectively attenuated CoP-induced osteolysis in mice. Additionally, it reversed osteogenic impairment in both CoP-stimulated mice and MC3T3-E1 cells. Mechanistically, this protection was mediated by activating the Wnt/β-catenin signalling pathway in both in vivo and in vitro models. Notably, inhibiting the Wnt signalling pathway with XAV939 abolished the protective effects of Mor in both models. These findings indicate that Mor alleviates CoP-induced osteolysis by restoring osteogenic function via the Wnt/β-catenin pathway, highlighting its potential as a therapeutic agent for PPO.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China; State Key Laboratory of Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture, Nanjing University…
- School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China.
- School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China. Electronic address: zhangsci@njucm.edu.cn.
- Center of Orthopedics, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing Key Laboratory of Spinal Disease Therapy and Regeneration (Military-Civilian), Chongqing 400042, China. Elec…
Förderung
- Nanjing University
- Chongqing Natural Science Foundation
- Nanjing University of Chinese Medicine
- National Natural Science Foundation of China
Zitieren
APA
Han, J., Zhu, Z., Gao, S., Wu, B., Meng, M., Zhang, S., & Wang, D. (2026). Morroniside alleviates CoCrMo particle-induced osteogenic impairment by activating Wnt/β-catenin signalling. Cellular Signalling, 146, 112687. https://doi.org/10.1016/j.cellsig.2026.112687
Vancouver
Han J, Zhu Z, Gao S, Wu B, Meng M, Zhang S, et al. Morroniside alleviates CoCrMo particle-induced osteogenic impairment by activating Wnt/β-catenin signalling. Cellular Signalling. 2026;146:112687. doi:10.1016/j.cellsig.2026.112687
BibTeX
@article{Han2026,
author = {Han, Jing and Zhu, Zhiqi and Gao, Shiya and Wu, Bingrong and Meng, Mingsong and Zhang, Sen and Wang, Dongsheng},
title = {Morroniside alleviates CoCrMo particle-induced osteogenic impairment by activating Wnt/β-catenin signalling},
journal = {Cellular Signalling},
year = {2026},
volume = {146},
pages = {112687},
doi = {10.1016/j.cellsig.2026.112687}
}
EUVIMED